Richard William Scalzo, SVP, Head of Finance & Administration at Dyne Therapeutics, Inc. (DYN), sold 4,714 shares at $28.20 ($133K) on 2024-05-16, disclosed to the SEC on 2024-05-17.
Scheduled sale ($133k) by SVP, Head of Finance & Administration under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.20 | 2,126 | $60K | 45.0% |
| 2 | $28.20 | 2,126 | $60K | 45.0% |
| 3 | $28.59 | 462 | $13K | 9.9% |
| Total | $28.24 avg | 4,714 | $133K | 100% |
| Filing → |
| DYN | SELL | 2025-03-13 | $15K | — | Filing → |
| DYN | SELL | 2025-03-07 | $11K | — | Filing → |
| DYN | SELL | 2025-02-18 | $35K | — | Filing → |